REGEN BIOPHARMA, INC. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
REGEN BIOPHARMA, INC. (RGBP) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $3.34 thousand for the 3-month period ending 2017-03-31, per its 10-K filed 2018-12-27.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2018-12-27
- REGEN BIOPHARMA, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2017-03-31 was $3.34K, a 98.65% decline year-over-year.
- REGEN BIOPHARMA, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2016-12-31 was $5.24K, a 97.88% decline year-over-year.
- REGEN BIOPHARMA, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2016-09-30 was $106.67K, a 56.92% decline year-over-year.
- REGEN BIOPHARMA, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2016-06-30 was $247.74K, a 0.06% increase year-over-year.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2017-03-31 | $3.34K 10-K · filed 2018-12-27 | $8.58K derived: sum of 2 quarters · filed 2018-12-27 | $115.25K derived: sum of 3 quarters · filed 2018-12-27 | $362.99K derived: sum of 4 quarters · filed 2018-12-27 |
| 2016-12-31 | $5.24K 10-K · filed 2018-12-27 | $111.91K derived: sum of 2 quarters · filed 2018-12-27 | $359.64K derived: sum of 3 quarters · filed 2018-12-27 | $607.38K derived: sum of 4 quarters · filed 2018-12-27 |
| 2016-09-30 | $106.67K 10-K · filed 2018-01-05 | $354.40K derived: sum of 2 quarters · filed 2018-01-05 | $602.14K derived: sum of 3 quarters · filed 2018-01-05 | $849.87K derived: sum of 4 quarters · filed 2018-01-05 |
| 2016-06-30 | $247.74K 10-K · filed 2018-01-05 | $495.48K derived: sum of 2 quarters · filed 2018-01-05 | $743.20K derived: sum of 3 quarters · filed 2018-01-05 | $990.79K derived: sum of 4 quarters · filed 2018-01-05 |
| 2016-03-31 | $247.74K 10-K · filed 2018-01-05 | $495.46K derived: sum of 2 quarters · filed 2018-01-05 | $743.05K derived: sum of 3 quarters · filed 2018-01-05 | $990.64K derived: sum of 4 quarters · filed 2018-01-05 |
| 2015-12-31 | $247.72K 10-K · filed 2018-01-05 | $495.31K derived: sum of 2 quarters · filed 2018-01-05 | $742.90K derived: sum of 3 quarters · filed 2018-01-05 | $875.50K derived: sum of 4 quarters · filed 2018-01-05 |
| 2015-09-30 | $247.59K 10-K/A · filed 2017-04-28 | $495.18K derived: sum of 2 quarters · filed 2017-04-28 | $627.78K derived: sum of 3 quarters · filed 2017-04-28 | |
| 2015-06-30 | $247.59K 10-K/A · filed 2017-04-28 | $380.19K derived: sum of 2 quarters · filed 2017-04-28 | ||
| 2015-03-31 | $132.60K 10-K/A · filed 2017-04-28 |